CMS Acupuncture for Fibromyalgia Coverage Policy (NCD 283): What Billing Teams Need to Know in 2026

The Centers for Medicare & Medicaid Services (CMS) has modified NCD 283, its National Coverage Determination governing acupuncture for fibromyalgia. This policy update confirms the long-standing non-coverage position that has been in place since April 2004—meaning claims for acupuncture billed under a fibromyalgia diagnosis remain non-covered under Medicare, regardless of clinical context. If your practice bills acupuncture services for Medicare beneficiaries, understanding the exact scope of this NCD is essential to avoiding denials and potential compliance exposure.

CMS NCD 283: What the Acupuncture for Fibromyalgia Policy Actually Says

CMS defines acupuncture broadly under this NCD as "the selection and manipulation of specific acupuncture points by a variety of needling and non-needling techniques." The policy applies across multiple Medicare benefit categories, including incident-to a physician's professional service, inpatient hospital services, and physicians' services.

The core determination has not changed since CMS first codified it in April 2004: acupuncture for fibromyalgia is nationally non-covered. CMS concluded at that time—and continues to hold—that there is no convincing evidence supporting acupuncture for pain relief in patients with fibromyalgia.

The agency cited study design flaws as the reason it cannot assess acupuncture's utility for improving health outcomes in this patient population. As a result, CMS determined that acupuncture does not meet the "reasonable and necessary" standard under §1862(a)(1) of the Social Security Act when used to treat fibromyalgia. This 2026 modification reaffirms that determination.

What "Nationally Non-Covered" Means for Medicare Billing

A National Coverage Determination carries significant weight in Medicare billing. Unlike a Local Coverage Determination (LCD), which applies only within a specific Medicare Administrative Contractor (MAC) jurisdiction, an NCD applies to all Medicare claims nationwide. There are no exceptions, no contractor-level overrides, and no medical necessity arguments that can overcome a national non-coverage designation for the specific indication at issue.

For NCD 283, this means:

• There are no nationally covered indications for acupuncture when the treating diagnosis is fibromyalgia. Section B of the policy explicitly states "N/A" under nationally covered indications.
• The non-coverage is absolute for this indication. CMS language confirms the "national non-coverage determination for acupuncture for fibromyalgia continues" as of the 2026 modification.
• No prior authorization pathway exists because prior auth is only relevant where coverage is at least conditionally available. This service is simply not covered under Medicare for fibromyalgia.

This distinction matters for your billing team. Submitting these claims—even with a modifier indicating the patient was informed of non-coverage—requires an Advance Beneficiary Notice of Non-Coverage (ABN) to be on file if you intend to bill the patient directly. Without a valid ABN, you cannot shift financial liability to the Medicare beneficiary.

The Reasonable and Necessary Standard Under §1862(a)(1)

CMS bases its non-coverage determination on §1862(a)(1) of the Social Security Act, which excludes from Medicare coverage any items or services that are not "reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member."

This is the foundational medical necessity standard in Medicare. When CMS issues an NCD citing this section, it is making a nationwide determination that the clinical evidence—at the time of review—does not support coverage. The April 2004 review underlying this NCD found that available research had significant study design flaws that prevented a confident assessment of acupuncture's effectiveness for fibromyalgia pain relief.

Importantly, CMS has not classified acupuncture for fibromyalgia as experimental or investigational in the same sense that some technologies receive. It is simply determined to be not reasonable and necessary for this specific indication—a coverage distinction that has downstream implications for how you document and communicate with patients.

How This NCD Interacts with Other Acupuncture Coverage Policies

It is worth noting what this NCD does not affect. CMS has separate coverage policy for acupuncture in the context of chronic low back pain, which has its own NCD (NCD 30.3.3) and is covered under specific criteria for Medicare beneficiaries. NCD 283 is narrowly scoped to fibromyalgia as the treatment indication.

If a patient presents with both fibromyalgia and chronic low back pain, the diagnosis code driving the acupuncture claim matters enormously. Billing acupuncture against a low back pain diagnosis—when the service is clinically documented as treating low back pain—is a different situation than billing against a fibromyalgia diagnosis. Your documentation must clearly support the indication being billed. Mismatched diagnosis coding is a compliance risk regardless of what the patient's broader medical history includes.

Affected Codes

The policy document for NCD 283 does not list specific CPT or HCPCS codes. CMS references claims processing instructions under Transmittal 10128 (Medicare Claims Processing) for operational guidance. Billing teams should consult their MAC's local guidance and the CMS Claims Processing Manual for code-level specifics.

No specific CPT, HCPCS Level II, or ICD-10-CM codes are enumerated in the NCD 283 policy document. Do not assume code-level coverage based on this NCD alone—verify with your MAC.

What Your Billing Team Should Do